Biotechnology
Pfizer wants in on the weight loss drug market – and upcoming data will be crucial for its success
CFOTO | Future Publishing | Getty Images As its Covid gains evaporate, Pfizer wants a chunk of the budding weight loss drug market. Analysts say upcoming data on Pfizer’s experimental obesity pill, danuglipron, will be crucial in determining how competitive the company can be against the space’s dominant players Eli Lilly and Novo Nordisk. Those […]
Read More
FDA approves Eli Lilly’s tirzepatide for weight loss, paving way for wider use of blockbuster drug
A pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating type 2 diabetes made by Novo Nordisk, at Rock Canyon Pharmacy in Provo, Utah, on March 29, 2023. George Frey | Reuters The Food and Drug Administration on Wednesday approved Eli Lilly‘s blockbuster drug tirzepatide for weight loss, paving the way for […]
Read More
Why oil is down considering that the Hamas-Israel conflict started out and whether or not that can very last
Oil charges have fallen to 3 thirty day period lows as world-wide electricity marketplaces largely dismiss fears of a close to-expression chance that the Israel-Hamas war could escalate into broader regional conflict that causes a key disruption to crude source. Brent crude futures and West Texas Intermediate slid to their lowest concentrations considering that July […]
Read More
Pharmacy walkout organizers help launch national push to unionize pharmacists, technicians
A small number of employees and supporters picket outside the headquarters of drugstore chain Walgreens during a three-day walkout by pharmacists in Deerfield, Illinois, November 1, 2023. Vincent Alban | Reuters The organizers of a recent retail pharmacy staff walkout are helping to launch a national push to organize those employees on Wednesday, a potential […]
Read More
U.S. crude oil prices slide down below $78 a barrel to their cheapest because July
An oil pumpjack pulls oil from the Permian Basin oil area in Odessa, Texas, on March 14, 2022. Joe Raedle | Getty Images Information | Getty Visuals U.S. crude price ranges on Tuesday fellow below $78 a barrel to hit the cheapest place given that July as weak world financial info overshadowed concerns that the […]
Read More
Novo Nordisk says 80% of insured U.S. patients taking Wegovy pay less than $25 a month
Still life of Wegovy an injectable prescription weight loss medicine that has helped people with obesity. It should be used with a weight loss plan and physical activity. Michael Siluk | UCG | Getty Images Novo Nordisk on Thursday said 80% of U.S. patients with insurance coverage who take its highly popular weight loss treatment […]
Read More
Eli Lilly says supply of blockbuster diabetes drug Mounjaro has improved in U.S.
A pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating type 2 diabetes made by Novo Nordisk, at Rock Canyon Pharmacy in Provo, Utah, March 29, 2023. George Frey | Reuters Eli Lilly on Thursday said supply of its blockbuster diabetes drug Mounjaro has improved in the U.S. after months of widespread […]
Read More
Pounds-loss drug Wegovy could get expanded Food and drug administration approval inside of six months, Novo Nordisk states
Even now daily life of Wegovy an injectable prescription fat decline medication that has aided people with being overweight. It should be made use of with a bodyweight loss system and physical activity. Michael Siluk | UCG | Getty Photographs Novo Nordisk said Thursday that its blockbuster bodyweight-reduction drug Wegovy could acquire expanded acceptance from […]
Read More
Moderna stock falls 10% as hefty Covid vaccine write-downs drive big loss
Moderna on Thursday posted a steep loss for the third quarter as the drugmaker recorded a large write-down due to unused doses of its Covid vaccine, its only marketable product. Moderna’s total revenue for the period topped Wall Street’s expectations, even amid plummeting demand for its shot. Its outlook for next year, however, came in […]
Read More
Eli Lilly results top estimates on Mounjaro strength but slashes full-year profit outlook
Eli Lilly and Company, Pharmaceutical company headquarters in Alcobendas, Madrid, Spain. Cristina Arias | Cover | Getty Images Eli Lilly on Thursday reported third-quarter revenue and adjusted earnings that topped estimates on strong demand for its diabetes drug Mounjaro, but slashed its full-year profit guidance due to charges primarily related to its recent acquisitions. Here’s […]
Read More